Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1965 1
1966 1
1981 1
1983 2
1984 3
1987 2
1989 2
1999 2
2000 1
2002 4
2003 3
2004 2
2005 6
2006 2
2007 4
2008 2
2010 6
2011 11
2012 17
2013 16
2014 25
2015 24
2016 25
2017 33
2018 37
2019 37
2020 42
2021 57
2022 38
2023 46
2024 46
2025 120
2026 73

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

613 results

Results by year

Filters applied: . Clear all
Page 1
Sensory neurons drive pancreatic cancer progression through glutamatergic neuron-cancer pseudo-synapses.
Ren L, Liu C, Çifcibaşı K, Ballmann M, Rammes G, Mota Reyes C, Tokalov S, Klingl A, Grünert J, Goyal K, Neckel PH, Mattheus U, Schoeps B, Yıldızhan SE, Sezerman OU, Cevik NC, Sever EA, Karakas D, Safak O, Steiger K, Muckenhuber A, Görgülü K, Chen Z, Zhang J, Ye L, Maula Ali MI, Tiwari VK, Romanyuk N, Giesert F, Saur D, Rad R, Schmid RM, Algül H, Krüger A, Friess H, Ceyhan GO, Istvanffy R, Demir IE. Ren L, et al. Among authors: goyal k. Cancer Cell. 2025 Dec 8;43(12):2241-2258.e8. doi: 10.1016/j.ccell.2025.09.003. Epub 2025 Sep 25. Cancer Cell. 2025. PMID: 41005304 Free article.
Guselkumab binding to CD64+ IL-23-producing myeloid cells enhances potency for neutralizing IL-23 signaling.
Sachen KL, Hammaker D, Sarabia I, Stoveken B, Hartman J, Leppard KL, Manieri NA, Bao P, Greving C, Lacy ER, DuPrie M, Wertheimer J, Deming JD, Brown J, Hart A, Li HH, Freeman TC, Keyes B, Kohler K, White I, Karpowich N, Steele R, Elloso MM, Fakharzadeh S, Goyal K, Lavie F, Abreu MT, Allez M, Atreya R, Bissonnette R, Eyerich K, Krueger JG, McGonagle D, McInnes IB, Ritchlin C, Fourie AM. Sachen KL, et al. Among authors: goyal k. Front Immunol. 2025 Mar 12;16:1532852. doi: 10.3389/fimmu.2025.1532852. eCollection 2025. Front Immunol. 2025. PMID: 40145093 Free PMC article.
Authors' response.
Soni SL, Kajal K, Yaddanapudi LN, Malhotra P, Puri GD, Bhalla A, Singh MP, Sehgal IS, Koushal V, Varma N, Biswal M, M Lakshmi PV, Sharma S, Suri V, Deepy Z, Ram S, Yadav J, Pandey N, Sharma P, Malik N, Goyal K, Mehra A, Sahoo S, Mohindra R, Francis J, Bhargava M, Singla K, Babu P, Verma A, Khaire NS, Guru RR. Soni SL, et al. Among authors: goyal k. Indian J Med Res. 2022 Oct-Nov;156(4&5):691-692. doi: 10.4103/0971-5916.371296. Indian J Med Res. 2022. PMID: 36926791 Free PMC article. No abstract available.
CXCR4-targeted therapy in lung cancer: plerixafor as a promising antimetastatic agent.
Ramalingam PS, Afzal M, Babu MA, Rekha MM, Sahoo S, Pandey SN, Goyal K, Hussain MS, Gupta G, Balakrishnan P, Arumugam S. Ramalingam PS, et al. Among authors: goyal k. Front Pharmacol. 2025 Nov 26;16:1683585. doi: 10.3389/fphar.2025.1683585. eCollection 2025. Front Pharmacol. 2025. PMID: 41383468 Free PMC article. Review.
AZGP1: A proteomic biomarker in cancer.
Pandey SN, Afzal M, Ali H, Malathi H, Maharana L, Goyal K, Rana M, Imran M. Pandey SN, et al. Among authors: goyal k. Clin Chim Acta. 2025 Sep 1;577:120481. doi: 10.1016/j.cca.2025.120481. Epub 2025 Jul 12. Clin Chim Acta. 2025. PMID: 40659174 Review.
613 results